Get started
Author

Maria‐Rosa Ghigna

Observed names: Ghigna Maria-Rosa, Ghigna, Maria, Ghigna, Maria-Rosa, M GHIGNA, M. -R. Ghigna, M. Ghigna, M. R. Ghigna, M. Roas Ghigna, M.-R. Ghigna, M.R. Ghigna, MR Ghigna, Maria Ghigna, Maria R. Ghigna, Maria Rosa Ghigna, Maria-Rosa Ghigna, Maria-Rosa Ghigna-Bellinzoni
Observed institutions: Université Paris-Sud, Inserm, University of Pavia, Universitätsklinikum Gießen und Marburg, Université Paris-Saclay, Institut Gustave Roussy, Laboratoire de Mathématiques d'Orsay, Assistance Publique – Hôpitaux de Paris, Hypertension pulmonaire : physiopathologie et innovation thérapeutique, Hôpital Marie Lannelongue, German Center for Lung Research, Hôpital Paris Saint-Joseph, Policlinico San Matteo Fondazione, Laboratoire Adhésion et inflammation, Bicêtre Hospital, Hôpital Paul-Brousse, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique, Fondation Gustave Roussy
ORCID: 0000-0001-5996-665X
Observed ORCID: 0000-0001-5996-665X
OpenAlex ID: A5081977372
Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
2014 · Peter Dorfmüller, Sven Günther, et al. · European Respiratory Journal · 287
Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma†
2012 · Sacha Mussot, Maria-Rosa Ghigna, et al. · European Journal of Cardio-Thoracic Surgery · 170
Small-Cell Carcinoma in the Setting of Pulmonary Adenocarcinoma: New Insights in the Era of Molecular Pathology
2013 · Emma Norkowski, Maria-Rosa Ghigna, et al. · Journal of Thoracic Oncology · 119
Solitary Fibrous Tumor of the Pleura: Outcomes of 157 Complete Resections in a Single Center
2012 · Benoit Lahon, Olaf Mercier, et al. · The Annals of Thoracic Surgery · 104
PDF
BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension
2016 · Maria-Rosa Ghigna, Christophe Guignabert, et al. · European Respiratory Journal · 97
PDF
1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial
2020 · B. Besse, J. Adam, et al. · Annals of Oncology · 91
Type or extension of intestinal metaplasia and immature/atypical “indefinite-for-dysplasia” lesions as predictors of gastric neoplasia✯
2006 · F TAVA, O LUINETTI, et al. · Human Pathology · 86
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension
2022 · Bastien Masson, Hélène Le Ribeuz, et al. · Circulation Research · 82
PDF
Conservative surgery plus brachytherapy treatment for boys with prostate and/or bladder neck rhabdomyosarcoma: a single team experience
2009 · Hélène Martelli, Christine Haie-Meder, et al. · Journal of Pediatric Surgery · 81
Phenotype and outcome of pulmonary arterial hypertension patients carrying aTBX4mutation
2020 · Pierre Thoré, Barbara Girerd, et al. · European Respiratory Journal · 74
Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease
2017 · Esther J. Nossent, Fabrice Antigny, et al. · The Journal of Heart and Lung Transplantation · 74
Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers
2019 · Claire MJ. Lefeuvre, Cloé A. Payet, et al. · Journal of Autoimmunity · 69
PDF
Patient‐derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management
2016 · Delphine Nicolle, Monique Fabre, et al. · Hepatology · 69
PDF
Validation of a Scoring System to Predict Recurrence of Resected Solitary Fibrous Tumors of the Pleura
2014 · Luis F. Tapias, Olaf Mercier, et al. · CHEST Journal · 67
PDF
Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue Using MALDI-ToF, ToF-SIMS, and Hybrid SIMS
2020 · Sebastiaan Van Nuffel, Marceau Quatredeniers, et al. · Analytical Chemistry · 56
PDF
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion
2023 · Mihaela Aldea, Arianna Marinello, et al. · Journal of Thoracic Oncology · 51
PDF
Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection
2010 · Eric Vibert, Jean-Charles Duclos-Vallée, et al. · Hepatology · 50
PDF
Characteristics and Long-term Outcomes of Pulmonary Venoocclusive Disease Induced by Mitomycin C
2020 · Marie-Caroline Certain, Marie-Camille Chaumais, et al. · CHEST Journal · 46
An emerging phenotype of pulmonary arterial hypertension patients carryingSOX17variants
2022 · David Montani, Benoit Lechartier, et al. · European Respiratory Journal · 45
PDF
Mediastinal tumours and pseudo-tumours: a comprehensive review with emphasis on multidisciplinary approach
2021 · Maria-Rosa Ghigna, Vincent Thomas de Montpreville · European Respiratory Review · 45
PDF
Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
2021 · Marceau Quatredeniers, Pedro Mendes-Ferreira, et al. · Cells · 45
PDF
Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease
2020 · Grégoire Manaud, Esther J. Nossent, et al. · American Journal of Respiratory Cell and Molecular Biology · 45
PDF
Thymic carcinomas: clinicopathologic study of 37 cases from a single institution
2013 · Vincent Thomas de Montpréville, Maria-Rosa Ghigna, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 44
Pulmonary vascular disease and pulmonary hypertension
2019 · Maria-Rosa Ghigna, Peter Dorfmüller · Diagnostic histopathology · 41
PDF
In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
2020 · Hélène Le Ribeuz, Audrey Courboulin, et al. · Respiratory Research · 38
PDF
Works count: 175
Citation count: 2,894
H-index: 33
I10-index: 60
Year
Topic
Type